Together, these results demonstrate the significance of ERRα-mediated up-regulation of AKR1C3 in the activation of AR signaling in prostate cancer cells through the enzymatic role of AKR1C3 in the backdoor pathway of androgen biosynthesis. Here, AR is linked to prostate carcinoma.